Hikma Pharmaceuticals Share News (HIK)
HIK Share
HIK Share
HIK Share
HIK Share
HIK
HIK Share
HIK Level 2
HIK Live
HIK Broker
HIK Directors
HIK Financial
HIK
HIK Short
HIK
Last checked at -
(For a live blog on European stocks, type LIVE/ in an Eikon news window)* Travel and leisure, basic resources stocks worst hit* WPP leads losses on STOXX 600 after bleak forecast* Standard Chartered, AB InBev latest victims of virus damage* Hikma P...
Read more* FTSE 100 down 3.5%, FTSE 250 slides 4.1%* Both indexes briefly in correction* StanChart slips after warning on virus hit* WPP slides as Q4 disappoints* Hikma outshines on bright forecast (Writes through)By Sagarika Jaisinghani, Devik Jain and Shas...
Read more(Corrects to say U.S. sales rose 5%, not 61%, and removes reference to double-digit growth across segments in paragraph four)* 2019 core sales and core oper. profit top expectations* Sees 2020 injectables sales growth in low to mid-single digits* ...
Read more* 2019 core sales and core oper. profit top expectations* Sees 2020 injectables sales growth in low to mid-single digits* Currently does not see material impact from coronavirus outbreak (Adds details on outlook, background)Feb 27 (Reuters) - Hikm...
Read more
(Sharecast News) - Hikma Pharmaceuticals reported a 6% improvement in group core revenue in its preliminary results on Thursday, to $2.2bn (£1.7bn).
Read more
UK Earnings, Trading Statements Calendar - Next 7 Days
Read more(Sharecast News) - Travis Perkins: Citigroup upgrades to buy with a target price of 1,900p.
Read more(Sharecast News) - Hikma Pharmatheuticals: Citigroup downgrades to neutral with a target price of 1,980p.
Read more(Adds detail on new venture)By Caroline HumerNEW YORK, Jan 23 (Reuters) - A group of Blue Cross Blue Shield insurers is investing $55 million in a venture that aims to offer cheaper prices to their members on generic drugs that currently have litt...
Read moreUK WINNERS & LOSERS SUMMARY: Spirent Up After Lifting Profit Guidance
Read more(Sharecast News) - British pharmaceutical company Hikma has inked an exclusive licensing and distribution agreement with Chiesi Farmaceutici, a research-focused business headquartered in Italy.
Read moreHikma Pharmaceuticals Signs Distribution Deal In Egypt With Chiesi
Read more(Sharecast News) - Polymetal International: Berenberg upgrades to buy with a target price of 1,480p.
Read moreHikma Teams With Arestat To Co-Develop Injectable Medicine In US
Read more(Sharecast News) - Hikma Pharmaceuticals on Thursday said it had signed a deal with Arecor to co-develop a ready-to-use injectable medicine in the US.
Read more
Last checked at